Education
About Us
Working with TipRanks
Follow Us
Cardlytics Inc (CDLX)
NASDAQ:CDLX
CDLX Stock Chart & Stats
$0.91
-$0.18(-5.23%)
At close: 4:00 PM EST
$0.91
-$0.18(-5.23%)
Day’s Range― - ―
52-Week Range$0.66 - $3.28
Previous CloseN/A
Volume316.83K
Average Volume (3M)769.48K
Market Cap
$50.19M
Enterprise Value$216.78M
Total Cash (Recent Filing)$48.72M
Total Debt (Recent Filing)$215.31M
Price to Earnings (P/E)―
Beta2.68
Next Earnings
May 06, 2026EPS Estimate
-0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding55,054,268
10 Day Avg. Volume930,764
30 Day Avg. Volume769,481
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-9.39
Price to Sales (P/S)0.26
P/FCF Ratio6.93
Enterprise Value/Market Cap4.32
Enterprise Value/Revenue0.93
Enterprise Value/Gross Profit2.06
Enterprise Value/Ebitda-3.27
Forecast
1Y Price Target
$1.08Price Target Upside18.68% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)-0.84
Revenue Forecast (FY)$219.14M
Bulls Say, Bears Say
Bulls Say
Asset SalePending sale of Bridg is expected to strengthen the company's balance sheet by converting a noncore unit into capital available to support operations.
Liquidity InjectionThe transaction provides liquid consideration in the form of buyer stock, which helps address liquidity concerns and eases short-term funding pressure.
Strategic FocusSale of the Bridg division allows focus on core operations and redirects resources toward higher-growth areas, improving operational efficiency.
Bears Say
Fragile Balance Sheet And Capital StructureCompany guidance points to a material revenue decline and analysts warn that the fragile balance sheet and current capital structure need meaningful strengthening before growth can reliably resume.
Loss Of Distribution PartnerTermination of the Bank of America relationship removes a major distribution channel and reduces access to a key customer base and revenue opportunities.
Partner-driven Billings DeclineContent restrictions at a major financial partner limited product offerings and drove a decline in billings, highlighting exposure to partner policies.
Cardlytics News
CDLX FAQ
What was Cardlytics Inc’s price range in the past 12 months?
Cardlytics Inc lowest stock price was $0.66 and its highest was $3.28 in the past 12 months.
What is Cardlytics Inc’s market cap?
Cardlytics Inc’s market cap is $50.19M.
When is Cardlytics Inc’s upcoming earnings report date?
Cardlytics Inc’s upcoming earnings report date is May 06, 2026 which is in 43 days.
How were Cardlytics Inc’s earnings last quarter?
Cardlytics Inc released its earnings results on Mar 04, 2026. The company reported -$0.15 earnings per share for the quarter, beating the consensus estimate of -$0.207 by $0.057.
Is Cardlytics Inc overvalued?
According to Wall Street analysts Cardlytics Inc’s price is currently Undervalued.
Does Cardlytics Inc pay dividends?
Cardlytics Inc does not currently pay dividends.
What is Cardlytics Inc’s EPS estimate?
Cardlytics Inc’s EPS estimate is -0.37.
How many shares outstanding does Cardlytics Inc have?
Cardlytics Inc has 55,054,268 shares outstanding.
What happened to Cardlytics Inc’s price movement after its last earnings report?
Cardlytics Inc reported an EPS of -$0.15 in its last earnings report, beating expectations of -$0.207. Following the earnings report the stock price went down -9.444%.
Which hedge fund is a major shareholder of Cardlytics Inc?
Currently, no hedge funds are holding shares in CDLX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cardlytics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.08 (18.68% Upside)
$1.08 (18.68% Upside)
Blogger Sentiment
Bullish
CDLX Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 588.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.59%
12-Months-Change
Fundamentals
Return on Equity
-370.98%
Trailing 12-Months
Asset Growth
-27.26%
Trailing 12-Months
Company Description
Cardlytics Inc
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.
CDLX Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture: meaningful operational and financial improvements (positive adjusted EBITDA, expense reductions, technology modernization, strong UK performance and notable advertiser wins) are offset by pronounced top-line pressure (material year-over-year declines in billings and revenue, a sharp Q1 guide decline, ACPU deterioration), the loss of a major FI partner (Bank of America), and the divestiture of Bridg that limits certain product capabilities in the near term. Management emphasizes a path to self-sustainability, sequential recovery, and several execution levers (new portfolios, UI enhancements, reinvestment in rewards, and Bridg proceeds to bolster the balance sheet) that could drive recovery later in 2026.View all CDLX earnings summariesCDLX Revenue Breakdown
94.25% U.S.
5.75% U.K.
CDLX Stock 12 Month Forecast
Average Price Target
$1.08
▲(18.68% Upside)
Technical Analysis
Ownership Overview
11.78% Insiders
6.28% Mutual Funds
21.39% Other Institutional Investors
55.92% Public Companies and
Individual Investors